Eclanamine
Eclanamine (U-48,753) is a drug which was patented as an antidepressant, but was never marketed.[1] It acts by inhibiting the reuptake of serotonin and norepinephrine.[2] Eclanamine was discovered by accident as a derivative of the κ-opioid receptor agonist U-50,488.[2]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
Chemical and physical data | |
Formula | C16H22Cl2N2O |
Molar mass | 329.27 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
References
- David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
- Progress in Medicinal Chemistry : Volume 29. Elsevier Science Pub Co. 1992. ISBN 978-0-444-89472-4.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.